The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What do we know and do we need to revise our expectations?

Epilepsy Research
Dieter SchmidtW Löscher

Abstract

Although surgery is often seen as a curative treatment for patients with drug-resistant temporal lobe epilepsy, little information is available how many cases can be considered cured after surgery, i.e. are seizure-free for several years without taking antiepileptic drugs (AEDs). In our review, 13 retrospective and five prospective clinical observations published since 1980 provided data on long-term seizure control off AEDs in a total of 1658 patients. No randomized studies were found. Following temporal lobe surgery, approximately one in four adult patients and approximately one in three children or adolescents can currently shown to be seizure-free for 5 years without AEDs (25%, mean of eight studies in adults, 95% CI: 21-30%, and 31%, mean of three studies in children, 95% CI: 20-41%). The rate of seizure control off AEDs seemed to be stable after 2 years of follow-up. However, as 55% of patients free of disabling seizures preferred not to discontinue their medication completely as late as 5 years after surgery, it is impossible to know if they are cured or not. No features predictive of surgical cure were detected except for better cure outcome in children versus adults with hippocampal sclerosis and in patients with typic...Continue Reading

References

Jan 11, 1991·Clinical Neurology and Neurosurgery·E Rossitch, B S Nashold
Nov 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·R D ElwesC E Polkey
Aug 14, 1996·JAMA : the Journal of the American Medical Association·M R SperlingC Plummer
Sep 1, 1996·Epilepsia·S S Spencer
Apr 1, 1997·Annals of Neurology·R S McLachlanJ P Girvin
Jun 1, 1997·Acta Neurologica Scandinavica·H C:son SilanderP Uvebrant
May 14, 1998·Epilepsia·W T Blume, J P Girvin
Jul 23, 1998·Neurology·J Maher, R S McLachlan
Jun 17, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H Jokeit, A Ebner
Aug 31, 2000·Pediatric Neurosurgery·A IannelliC Di Rocco
Feb 13, 2001·Surgical Neurology·A R Wyler
Aug 4, 2001·The New England Journal of Medicine·S WiebeUNKNOWN Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group
Aug 4, 2001·The New England Journal of Medicine·J Engel
Sep 19, 2002·Seizure : the Journal of the British Epilepsy Association·Eva KumlienJohn R Gates
Nov 27, 2002·Neurology·R G JarrarE Laws
Dec 24, 2002·Seizure : the Journal of the British Epilepsy Association·Carlos AmoTomás Ortiz
Jan 17, 2003·Mayo Clinic Proceedings·Richard S Zimmerman, Joseph I Sirven
Mar 21, 2003·Pediatric Neurosurgery·D Barry SinclairW Colmers
Mar 26, 2003·Seizure : the Journal of the British Epilepsy Association·Selim R BenbadisFernando L Vale
Apr 15, 2003·Journal of Neurosurgery·H Gregor WieserYasuhiro Yonekawa
Sep 16, 2003·Epilepsy Research·Heinz-Gregor Wieser, Adrian Häne

❮ Previous
Next ❯

Citations

Jan 8, 2008·Epilepsia·Arthur C GrantOrrin Devinsky
Oct 22, 2005·Acta Neurologica Scandinavica. Supplementum·J T Butler
Jan 8, 2018·Journal of Neurology·Barbara SchmeiserAndreas Schulze-Bonhage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.